• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SMART COIL; HCG, KRD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SMART COIL; HCG, KRD Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Convulsion/Seizure (4406)
Event Date 12/21/2021
Event Type  Injury  
Manufacturer Narrative
Potential adverse events in the labeling with the smart coil system include, but are not limited to, incomplete aneurysm occlusion, emboli, embolic stroke, and other cerebral ischemic events, including death.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.The product lot number was not provided, therefore, the manufacturing records could not be reviewed.
 
Event Description
On (b)(6) 2021, the patient underwent a coil embolization procedure in the v4 segment of the posterior circulation using penumbra smart coils (smart coil).On (b)(6) 2021, the patient showed increased aphasia with a national institutes of health stroke scale (nihss) of 5.However, the computed tomography angiography (cta) and magnetic resonance imaging (mri) showed no change with all symptoms resolved.On (b)(6) 2021, the patient returned to the emergency department (ed) due to sudden-onset confusion with a nihss of 2 for complete hemianopsia.The cta was negative, and the mri showed three punctate acute infarcts in the right cerebellar hemisphere.It was also reported that the seizure was presumed to be secondary to the punctate stroke.This event was considered resolved as of (b)(6) 2021.The punctate stroke and seizure were reported to be serious adverse events with a probable relationship to the index procedure and a possible relationship to the smart coil system.
 
Manufacturer Narrative
Please note that the following section was updated based on the additional information provided by the clinical investigator on 20-jan-22: 1.Section b.Box 5.Describe event or problem.H3 other text : placeholder.
 
Event Description
On (b)(6) 2021, the patient underwent a coil embolization procedure in the v4 segment of the posterior circulation using penumbra smart coils (smart coil).On (b)(6) 2021, the patient returned to the emergency department (ed) due to sudden-onset confusion with a national institutes of health stroke scale (nihss) of 2 for complete hemianopsia.The computed tomography angiography (cta) was negative, and the magnetic resonance imaging (mri) showed three punctate acute infarcts in the right cerebellar hemisphere.The patient was admitted to the neuro floor.On (b)(6) 2021, the patient showed increased aphasia with a nihss of 5.However, the cta and mri showed no change with all symptoms resolved.It was also reported that the seizure was presumed to be secondary to the punctate stroke.This event was considered resolved as of (b)(6) 2021.The punctate stroke and seizure were reported to be serious adverse events with a probable relationship to the index procedure and a possible relationship to the smart coil system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SMART COIL
Type of Device
HCG, KRD
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key13287511
MDR Text Key286583366
Report Number3005168196-2022-00016
Device Sequence Number1
Product Code HCG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K160832
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/01/2005,02/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/18/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received01/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age72 YR
Patient SexFemale
-
-